Mark Angelo

Mark Angelo is an accomplished healthcare executive with a proven track record for leading high growth healthcare provider organizations in both the US and Canada. As CEO of LMC Diabetes & Endocrinology and Manna Research, Mark is responsible for providing strategic and day-to-day leadership of the organization, overseeing operations, strategy and business development.  Prior to joining LMC, Mark was Vice President, Innovation and Business Development at Hospital for Special Surgery (HSS), an academic medical center in New York City that is a global leader in orthopedic care.  There, Mark was responsible for advancing hospital strategic priorities related to operational excellence, innovation, business development and growth.  Prior to HSS, Mark was a management consultant at Monitor Group (now Monitor Deloitte) where he worked with Fortune 500 companies and non-profits across a variety of industries on strategic initiatives related to growth and operational improvement.  Mark has a Bachelor of Applied Science in Biomedical Engineering from the University of Toronto and a Master of Business Administration from Harvard Business School.